scholarly journals Growth hormone treatment impact on growth rate and final height of patients who received HSCT with TBI or/and cranial irradiation in childhood: a report from the French Leukaemia Long-Term Follow-Up Study (LEA)

2011 ◽  
Vol 47 (5) ◽  
pp. 684-693 ◽  
Author(s):  
F Isfan ◽  
J Kanold ◽  
E Merlin ◽  
A Contet ◽  
N Sirvent ◽  
...  
Keyword(s):  
Growth Hormone ◽  
Growth Rate ◽  
Growth Hormone Treatment ◽  
Final Height ◽  
Hormone Treatment ◽  
Cranial Irradiation ◽  
Follow Up Study ◽  
Long Term Follow Up

The Influence of Growth Hormone Treatment on Glucose Homeostasis in GrowthHormone-Deficient Children: A Six-Year Follow-Up Study

2016 ◽  
Vol 86 (3) ◽  
pp. 196-200 ◽  
Author(s):  
Federico Baronio ◽  
Laura Mazzanti ◽  
Ylenia Girtler ◽  
Federica Tamburrino ◽  
Anisia Fazzi ◽  
...  
Keyword(s):  
Growth Hormone ◽  
Glucose Homeostasis ◽  
Growth Hormone Treatment ◽  
Hormone Treatment ◽  
Follow Up Study

Improved final height with long-term growth hormone treatment in Noonan syndrome

2007 ◽  
Vol 94 (9) ◽  
pp. 1232-1237 ◽  
Author(s):  
Deborah Osio ◽  
Jovanna Dahlgren ◽  
Kerstin Albertsson Wikland ◽  
Otto Westphal
Keyword(s):  
Growth Hormone ◽  
Noonan Syndrome ◽  
Growth Hormone Treatment ◽  
Final Height ◽  
Hormone Treatment

Final Height after Long-Term Growth Hormone Treatment in Thai Children with Turner Syndrome

1998 ◽  
Vol 49 (Suppl. 1) ◽  
pp. 55-55 ◽  
Author(s):  
Pat Mahachoklertwattana ◽  
Chawalit Preeyasombat ◽  
Lulin Choubtum ◽  
Arporn Sriphrapradang
Keyword(s):  
Growth Hormone ◽  
Turner Syndrome ◽  
Growth Hormone Treatment ◽  
Final Height ◽  
Hormone Treatment

scholarly journals LONG TERM FOLLOW-UP OF ONE OF THE FIRST PATIENTS TO RECEIVE HUMAN GROWTH HORMONE THERAPY

2020 ◽  
Vol 6 (5) ◽  
pp. e262-e264
Author(s):  
Cassandra Hawco ◽  
Robyn L. Houlden
Keyword(s):  
Growth Hormone ◽  
Medical Center ◽  
Final Height ◽  
Sella Turcica ◽  
Hormone Deficiency ◽  
Pituitary Hormone ◽  
Long Term Follow Up ◽  
To Receive

Objective: Treatment of growth hormone (GH) deficiency with GH extracts from human pituitary glands was introduced by Dr. Maurice Raben at Tufts New England Medical Center in 1956. We report long term follow-up of one of the first patients treated with GH. Methods: Clinical, radiographic, and genetic data are presented. Results: A 78-year-old man presented for follow-up. He was one of the first patients to receive GH therapy from Raben in 1958. Growth was reported as normal until age 3 and then decelerated. At age 17 years, he was 129.5 cm with absent sexual development and bone age of 7 years. Treatment was initiated with desiccated thyroid and cortisone acetate for 8 months. Human GH extract was then initiated with 2 mg 3 times/week for 2 years, then 3 mg 3 times/week for 6 months, resulting in a final height of 168.9 cm. Testosterone intramuscularly every 2 weeks was added with sexual maturation over 2 years. He remained on testosterone injections until the age of 40 years, and on transdermal testosterone until the age of 50 years. At age 27 years, he was treated by Raben with human chorionic gonadotropin and menotropins for spermatogenesis restoration with successful conception by his wife. At age 78 years, pituitary MRI revealed a tiny amount of pituitary tissue within normal-sized sella turcica with absent pituitary infundibulum. A combined pituitary hormone deficiency genetic panel did not reveal any mutations. Conclusion: Sixty-two years later, the patient remains in good health and grateful to a pioneer in Endocrinology for groundbreaking therapy of short stature. The cause of his hypopituitarism remains unknown.

Effect of Long-Term Growth Hormone Treatment on Final Height of Children with Russell-Silver Syndrome

2010 ◽  
Vol 74 (3) ◽  
pp. 212-217 ◽  
Author(s):  
Meropi Toumba ◽  
Assunta Albanese ◽  
Cristina Azcona ◽  
Richard Stanhope
Keyword(s):  
Growth Hormone ◽  
Growth Hormone Treatment ◽  
Final Height ◽  
Hormone Treatment ◽  
Silver Syndrome
Sign in / Sign up

Export Citation Format

Share Document